SEMICONDUCTOR ELEMENT, METHOD OF MANUFACTURING FINE STRUCTURE ARRANGING SUBSTRATE, AND DISPLAY ELEMENT
    5.
    发明申请
    SEMICONDUCTOR ELEMENT, METHOD OF MANUFACTURING FINE STRUCTURE ARRANGING SUBSTRATE, AND DISPLAY ELEMENT 审中-公开
    半导体元件,制造微结构基板的方法和显示元件

    公开(公告)号:US20110058126A1

    公开(公告)日:2011-03-10

    申请号:US12867725

    申请日:2009-02-10

    摘要: With reference to a direction perpendicular to a direction of forming electrodes to which a voltage can be applied, fine structures are each arranged within ±5 degrees at a substantially even interval, and a semiconductor element is formed by using the fine structures. On an insulating substrate, at least two electrodes are arranged at a predetermined interval, and there are formed one or more fine structure arranging regions, each of which is formed by a unit of the two electrodes. A semiconductor element electrode is made in contact with the plurality of the fine structures, each having two ends in contact with the two electrodes and a length in a longitudinal direction of a nano order to a micron order, and arranged within ±5 degrees with reference to the direction perpendicular to the direction of forming the electrodes.

    摘要翻译: 关于与形成可施加电压的电极的方向垂直的方向,精细结构以基本上均匀的间隔布置在±5度内,并且通过使用精细结构形成半导体元件。 在绝缘基板上,至少两个电极以预定间隔布置,并且形成一个或多个精细结构布置区域,每个电极由两个电极的单元形成。 半导体元件电极与多个精细结构接触,每个微结构具有与两个电极接触的两个端部,并且在纵向方向上的长度为纳米级至微米级,并且以参考方式布置在±5度内 到垂直于形成电极的方向的方向。

    Remedies for heart diseases
    8.
    发明申请
    Remedies for heart diseases 审中-公开
    心脏病的治疗方法

    公开(公告)号:US20050003455A1

    公开(公告)日:2005-01-06

    申请号:US10486233

    申请日:2002-08-07

    摘要: This invention aims at providing a method of searching for substances that can selectively suppress apoptosis in cardiovascular cells. This objective is attained by providing a method of screening for therapeutic and/or prophylactic agents of cardiac disease, which comprises the steps of inducing apoptosis in cultured myocardial cells and/or cultured vascular endothelial cells; treating the cells with a Cl− channel blocker under test; and evaluating the therapeutic and/or prophylactic effect of the blocker under test on cardiac disease by checking to see if it can suppress apoptotic cell death in the cardiovascular cells or vascular endothelial cells.

    摘要翻译: 本发明旨在提供一种能够选择性抑制心血管细胞凋亡的物质的方法。 该目的通过提供筛选心脏病治疗和/或预防药物的方法来实现,其包括在培养的心肌细胞和/或培养的血管内皮细胞中诱导细胞凋亡的步骤; 用被测试的Cl - 通道阻断剂处理细胞; 以及通过检查其是否可以抑制心血管细胞或血管内皮细胞中的凋亡性细胞死亡来评估受试者中的心脏病的治疗和/或预防效果。

    Method for inhibiting cell death, cell death inhibitor, and remedy for disease caused by cell death containing the cell death inhibitor
    9.
    发明申请
    Method for inhibiting cell death, cell death inhibitor, and remedy for disease caused by cell death containing the cell death inhibitor 审中-公开
    用于抑制细胞死亡,细胞死亡抑制剂和由含有细胞死亡抑制剂的细胞死亡引起的疾病的治疗方法

    公开(公告)号:US20060088552A1

    公开(公告)日:2006-04-27

    申请号:US10536797

    申请日:2003-11-27

    IPC分类号: A61K39/02

    CPC分类号: A61K38/164

    摘要: A method according to the present invention for inhibiting cell death includes administrating an anion channel-forming peptide to cells under lactacidosis. The anion channel-forming peptide forms an anion channel on a cell membrane artificially. A cell death inhibitor according to the present invention contains the anion channel-forming peptide. Some of examples of the anion channel-forming peptide are a VacA protein derived from Helicobacter pylori and a glycine receptor channel variant peptide. The method and cell death inhibitor according to the present invention are effective especially for necrotic cell death that accompanies cell swelling.

    摘要翻译: 根据本发明的用于抑制细胞死亡的方法包括将阴离子通道形成肽施用于乳酸脱氢酶下的细胞。 阴离子通道形成肽人造细胞膜上形成阴离子通道。 根据本发明的细胞死亡抑制剂含有阴离子通道形成肽。 阴离子通道形成肽的一些实例是来自幽门螺杆菌和甘氨酸受体通道变体肽的VacA蛋白。 根据本发明的方法和细胞死亡抑制剂特别适用于伴随细胞肿胀的坏死细胞死亡。